Managing the risk of nosocomial transmission of prion diseases

Current Opinion in Infectious Diseases

Volumn 15, Issue 4, 2002, Pages 421-425

  Weber, David J ^a   Rutala, William A ^a  

^a UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

CJD; Disinfection; Infection control; Sterilization; vCJD

Indexed keywords

ALCOHOL; AMMONIA; CHLORINE; CHLORINE DIOXIDE; DISINFECTANT AGENT; ETHYLENE OXIDE; FORMALDEHYDE; GLUTARALDEHYDE; HYDROCHLORIC ACID; HYDROGEN PEROXIDE; IODINE; PERACETIC ACID; PHENOL DERIVATIVE;

AUTOCLAVE; BLOOD DONOR; CLEANING; CREUTZFELDT JAKOB DISEASE; DISINFECTION; EPIDEMIOLOGICAL DATA; HEALTH CARE PERSONNEL; HIGH RISK POPULATION; HOSPITAL INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RATE; PRION DISEASE; REVIEW; SCREENING; VIRAL CONTAMINATION; VIRUS TRANSMISSION;

EID: 0036325263     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-200208000-00011     Document Type: Review

References (45)

1. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies
2. Human prion diseases
3. Shattuck lecture - Neurodegenerative diseases and prions
4. Gerstmann-Straussler-Sheinker syndrome, fatal familial insomnia, and kuru: A review of these less common human transmissible spongiform encephalopathies
5. Variant Creutzfeldt-Jakob disease
6. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease: Background, evolution, and current concerns
7. Variant Creutzfeldt-Jakob disease: A summary of current scientific knowledge in relation to public health
8. Management of equipment contaminated with the Creutzfeldt-Jakob disease agent
9. Creutzfeldt-Jakob disease: Recommendations for disinfection and sterilization
10. Creutzfeldt-Jakob disease: Risks and prevention of nosocomial acquisition
11. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease
12. Bse: A decade on - Part 1
13. Incidence of variant Creutzfeldt-Jakob disease in the UK
14. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease
15. Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-Jakob disease: Implications for human health
16. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy
17. Investigation of Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples
18. Prion immunoreactivity in appendix before clinical onset of Creutzfeldt-Jakob disease
19. Tissue distribution of protease resistant prior protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay
20. Biosafety issues in prion diseases
21. Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues
22. Iatrogenic Creutzfeldt-Jakob disease at the millennium
23. Bse transfusion through blood
24. Prions and transfusion medicine
25. Risk of acquiring Creutzfeldt-Jakob disease from blood transfusions: Systematic review of case-control studies
26. Surveillance for Creutzfeldt-Jakob disease among persons with hemophilia
27. Retrospective neuropathological review of prion disease in UK haemophilic patients
28. Is Creutzfeldt-Jakob disease transmitted in blood?
29. Creutzfeldt-Jakob disease after receipt of a previously unimplicated brand of dura mater graft
30. Vaccines and variant CJD
31. Suitability determination for donors of human cellular and tissue-based products
32. Eye banking and screening for Creutzfeldt-Jakob disease
33. Current issues in hospital hygiene and sterilization technology
34. Management of equipment contaminated with CJD agent
35. Sterilization of prions: Requirements, complications, implication
36. Activity of sterilization processes and disinfectants against prions (Creutzfeldt-Jakob disease agent)
37. Cross infection control measures and the treatment of patients at risk of Creutzfeldt-Jakob disease in UK general dental practice
38. CJD and the eye
39. Pharygoplasty and the risk of variant CJD transmission